Related references
Note: Only part of the references are listed.Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma
Matteo Costacurta et al.
HAEMATOLOGICA (2021)
Emerging functions of branched ubiquitin chains
Michael E. French et al.
CELL DISCOVERY (2021)
Cullin-RING Ubiquitin Ligase Regulatory Circuits: A Quarter Century Beyond the F-Box Hypothesis
J. Wade Harper et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 90, 2021 (2021)
An atlas of protein-protein interactions across mouse tissues
Michael A. Skinnider et al.
CELL (2021)
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique B. Alabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Rati Verma et al.
MOLECULAR CELL (2020)
Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide
Shumpei Tateno et al.
SCIENTIFIC REPORTS (2020)
Ubiquitin-dependent proteasomal degradation of AMPK gamma subunit by Cereblon inhibits AMPK activity
Seung-Joo Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Molecular mechanisms of thalidomide and its derivatives
Takumi Ito et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2020)
USP15 Deubiquitinates TUT1 Associated with RNA Metabolism and Maintains Cerebellar Homeostasis
Jaehyun Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2020)
USP15 Deubiquitinase Safeguards Hematopoiesis and Genome Integrity in Hematopoietic Stem Cells and Leukemia Cells
Paul van den Berk et al.
CELL REPORTS (2020)
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
Jiye Liu et al.
LEUKEMIA (2019)
RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation
Nan Zhou et al.
LEUKEMIA (2019)
The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors
Yihan Peng et al.
NATURE COMMUNICATIONS (2019)
Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4
Yuan Xiao Zhu et al.
BLOOD CANCER JOURNAL (2019)
Ubiquitin-Specific Protease 15 Maintains Transforming Growth Factor-β Pathway Activity by Deubiquitinating Transforming Growth Factor-β Receptor I during Wound Healing
Yixuan Zhao et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Branching Out: Improved Signaling by Heterotypic Ubiquitin Chains
Diane L. Haakonsen et al.
TRENDS IN CELL BIOLOGY (2019)
Development of targeted protein degradation therapeutics
Philip P. Chamberlain et al.
NATURE CHEMICAL BIOLOGY (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma
Ajinkya Patil et al.
BLOOD ADVANCES (2019)
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner
Konstantinos Dimopoulos et al.
MOLECULAR ONCOLOGY (2018)
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells
Achuth Padmanabhan et al.
NATURE COMMUNICATIONS (2018)
Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4(CRBN) activity
Quinlan L. Sievers et al.
BLOOD (2018)
UBE2G1 governs the destruction of cereblon neomorphic substrates
Gang Lu et al.
ELIFE (2018)
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
Katherine A. Donovan et al.
ELIFE (2018)
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
Da Zhou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates
Thang Van Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Ubiquitin Specific Peptidase 15 (USP15) suppresses glioblastoma cell growth via stabilization of HECTD1 E3 ligase attenuating WNT pathway activity
Maria Oikonomaki et al.
ONCOTARGET (2017)
Drugging the undruggables: exploring the ubiquitin system for drug development
Xiaodong Huang et al.
CELL RESEARCH (2016)
Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon
T. Van Nguyen et al.
MOLECULAR CELL (2016)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
Daniel J. Anderson et al.
CANCER CELL (2015)
Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
Alex J. Bott et al.
CELL METABOLISM (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
Saverio Tardito et al.
NATURE CELL BIOLOGY (2015)
Prime time for PROTACs
Raymond J. Deshaies
NATURE CHEMICAL BIOLOGY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination
Prasanna Vasudevan Iyengar et al.
SCIENTIFIC REPORTS (2015)
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone
E. M. Ocio et al.
LEUKEMIA (2015)
Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer et al.
NATURE (2014)
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Qiang Zou et al.
NATURE IMMUNOLOGY (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Cleaning up in the endoplasmic reticulum: ubiquitin in charge
John C. Christianson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
Maria Stella Ritorto et al.
NATURE COMMUNICATIONS (2014)
The Ubiquitin System, an Immense Realm
Alexander Varshavsky
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Development of proteasome inhibitors as research tools and cancer drugs
Alfred L. Goldberg
JOURNAL OF CELL BIOLOGY (2012)
Methods for Quantification of in vivo Changes in Protein Ubiquitination following Proteasome and Deubiquitinase Inhibition
Namrata D. Udeshi et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
SUMO-Specific Protease 1 Is Critical for Early Lymphoid Development through Regulation of STAT5 Activation
Thang Van Nguyen et al.
MOLECULAR CELL (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
Pieter J. A. Eichhorn et al.
NATURE MEDICINE (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu et al.
BLOOD (2011)
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Mikael Altun et al.
CHEMISTRY & BIOLOGY (2011)
Evidence of a Role for Activation of Wnt/β-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide
Chad C. Bjorklund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
USP15 is a deubiquitylating enzyme for receptor-activated SMADs
Masafumi Inui et al.
NATURE CELL BIOLOGY (2011)
Glutamine Synthetase Is a Genetic Determinant of Cell Type-Specific Glutamine Independence in Breast Epithelia
Hsiu-Ni Kung et al.
PLOS GENETICS (2011)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
COP9 Signalosome Interacts ATP-dependently with p97/Valosin-containing Protein (VCP) and Controls the Ubiquitination Status of Proteins Bound to p97/VCP
Sevil Cayli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Mechanism of auxin perception by the TIR1 ubiquitin ligase
Xu Tan et al.
NATURE (2007)
CSN controls NF-κB by deubiquitinylation of IκBα
Katrin Schweitzer et al.
EMBO JOURNAL (2007)
A genomic and functional inventory of deubiquitinating enzymes
SMB Nijman et al.
CELL (2005)
Brief report -: Congenital glutamine deficiency with glutamine synthetase mutations
J Häberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1
BKJ Hetfeld et al.
CURRENT BIOLOGY (2005)
COP9 signalosome: A multifunctional regulator of SCF and other cullin-based ubiquitin Ligases
GA Cope et al.
CELL (2003)
Fission yeast COP9/signalosome suppresses cullin acivity through recruitment of the deubiquitylating enzyme Ubp12p
CS Zhou et al.
MOLECULAR CELL (2003)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
